Back to Search Start Over

Synergistic antibiotic effect of looped antimicrobial peptide CLP-19 with bactericidal and bacteriostatic agents

Authors :
Zhiqiang Tian
Peiyuan Xia
Qian Wang
Yao Liu
Ya Yang
Jun Lv
Fengjun Sun
Di Li
Source :
Oncotarget
Publication Year :
2017
Publisher :
Impact Journals, LLC, 2017.

Abstract

// Di Li 1,2,* , Ya Yang 1,* , Zhiqiang Tian 3 , Jun Lv 1 , Fengjun Sun 1 , Qian Wang 1 , Yao Liu 1 and Peiyuan Xia 1 1 Department of Pharmacy, Southwest Hospital, Third Military Medical University, Chongqing, China 2 Department of Pharmacy, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China 3 Department of Immunology, Third Military Medical University, Chongqing, China * These authors have contributed equally to this work Correspondence to: Peiyuan Xia, email: // Yao Liu, email: // Keywords : antimicrobial peptides, CLP-19, synergistic effect, hydroxyl radicals, LPS, Immunology and Microbiology Section, Immune response, Immunity Received : January 17, 2017 Accepted :April 15, 2017 Published : May 23, 2017 Abstract The treatment of drug-resistant infections is complicated and the alarming rise in infectious diseases poses a unique challenge for development of effective therapeutic strategies. Antibiotic-induced liberation of the bacterial endotoxin lipopolysaccharide (LPS) may have immediate adverse effects promoting septic shock in patients. In the present study, we first confirmed our previous finding that looped antimicrobial peptide CLP-19 exerts non-specific direct antibacterial activity with no toxic to mammalian cells and second revealed that CLP-19 has synergistic effect to enhance the antibacterial activities of other conventional bactericidal (ampicillin and ceftazidime) and bacteriostatic (erythromycin and levofloxacin) agents. Third, the underlying mechanism of antibiotic effect was likely associated with stimulation of hydroxyl radical generation. Lastly, CLP-19 was shown to effectively reduce the antibiotic-induced liberation of LPS, through direct neutralization of the LPS. Thus, CLP-19 is a potential therapeutic agent for combinatorial antibiotic therapy.

Details

ISSN :
19492553
Volume :
8
Database :
OpenAIRE
Journal :
Oncotarget
Accession number :
edsair.doi.dedup.....07b5c97d6a840d27c0e24e3b089e0d26